• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Novo Nordisk A/S (NVO)

    -NYSE
    43.88 Down 0.37(0.84%) Jan 23, 4:02PM EST
    |After Hours : 43.88 0.00 (0.00%) Jan 23, 6:12PM EST
    Add to Portfolio
    Prev Close:44.25
    Open:44.18
    Bid:42.14 x 100
    Ask:43.89 x 200
    1y Target Est:49.83
    Beta:0.99
    Next Earnings Date:N/A
    Day's Range:43.85 - 44.41
    52wk Range:37.21 - 49.11
    Volume:1,878,215
    Avg Vol (3m):1,554,450
    Market Cap:114.70B
    P/E (ttm):28.60
    EPS (ttm):1.53
    Div & Yield:0.61 (1.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVODown 0.84%114.70B
    LLYDown 0.46%77.15B
    PFEDown 1.10%204.46B
    SNYUp 0.32%123.02B

    Key Statistics

    Forward P/E (1 yr):23.34
    P/S (ttm):8.62
    Ex-Dividend Date:21-Mar-14

    Analysts

    Annual EPS Est (Dec-14) :1.64
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.93

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback